Member Info for daveycaferacer

non-stop? hardly, check out Hannon for that, desperately talking his own book whilst also blatantly ramping ENQ

desperate? wrong again, I am well in profit on Tullow thanks.

your name tells us all we need to know - down but not out - YET = FILTERED

to the people who said this would drop to 30p in carapa was carapa, you were wrong, thankfully

some of the share price predictions on here are hilarious

Thanks to Lauders on advfn for this post today

HCM gets a mention in this review of 2019 and look ahead at 2020:-
Https://www.bioworld.com/articles/432068-year-in-review-from-capital-markets-to-crispr-2019-a-pretty-good-year-for-biopharma

oh the doomsters and the gloomsters who can never give any balance, just talking their own book

I cannot understand why anyone would still remain with a short position now, on balance there is no chance of any upside for shorts from here

""The Carapa-1 result is an important exploration outcome with positive implications for both the Kanuku and Orinduik blocks. " - It was never really about carapa in isolation. Today's news is not as negative as some are saying when they talk their own book

what happened to neil's 30p prediction? Another "forecast" he got totally wrong. This could and probably will end up positive today. carapa was already priced in.

There are some buffons on here aren't there nennyb.....

This could easily end up in positive territory by the end of the day

no sour grapes from me, I invested in Tullow @ 60p as it is a pure recovery play, and and will almost certainly be acquired by an Oil major, which will push the price in in January

I sold ENQ at around 100p when it was split from Petrofac and I now have a short position on it

UK markets close @ 12.30 today, hopefully we will get an update on Thursday or Friday

A wonderful and long awaited recovery seems to be underway, I am looking (hoping) for getting back to the mid $30's in 2020

I suppose we at the behest of Repsol

"grater" than 0.5%?

Here is my list of 2019 headwinds, most of which are receding or have gone, paving the way for a much better 2020,
especially as we are looking for accelerated Surufatinib approval in China and a possible China Savolitinib NDA

1. HHHL/CKH secondary listing overhang - probably cleared
2. U.S. - China trade war - partially cleared
3. Hong Kong riots - ongoing
4. Delay to HK IPO - Co. muted this will probably now happen at some point
5. Worldwide markets volatility - cleared
6. Trump China ADR de-listing threat - gone
7. Anti-Chinese sentiment by U.S. and its Investment Community - receding

I think 2020 could bring us an all-time high in excess of the previous 584p, although the rise of sterling against the U.S. dollar will be a slight headwind for the Ordinary Shares

Top 10 performers of the last decade

https://www.proactiveinvestors.co.uk/companies/news/909690/winners-of-the-decade-and-those-who-simply-decayed-909690.html

I have EAS ;o-)

old news

wouldn't be surprised to see this make 70p today once the U.S markets open

what did Dot say?